Fundamental Analysis of POINT Biopharma Global Inc - Growth / Value Index


PNT - Valuation Highlights

Valuation Analysis

   Tsr Value Index - Good Score of 68.75
   Price to Earning Ratio is 0.0159 and EV to EBITDA is 0.0123 suggesting company is undervalued.
   Price to Book Ratio is 0.0136 indicating that it is undervalued.
Valuation Key Ratios
Ratio TTM Latest FY Yoy Change MRQ
Price to Earning 0.0159 0.0122 100.12 %
Price to Book 0.0136 2.67 40.11 % 3.12
Price to Sales 0.0055 0.0053 0 %
Enterprise Value to EBITDA Multiple 0.0123 0.0092 100.17 %


PNT - Profitability Highlights

Profitability Analysis

   Earning Yield of 6293.28 %
   Net profit has jumped from negative to positive
   Company Earning excess return
   During the past twelve months, the company has given a strong Return On Equity of 85.82%
   During the past twelve months, the company has given a strong Return On Asset of 72.51%
   During the past twelve months, the company has given a strong Net Margin of 34.43%
   Good Return On Capital Employed of 20.19
   Very Low Dividend Yield of 0 %
   Negative Net Margin MRQ
Profitability Key Ratios
Ratio TTM Latest FY Yoy Change MRQ
Return On Equity 85.82 20185.33 112328 % -5.84
Return On Asset 72.51 18157.68 104237 % -5.19
Net Profit Margin 34.43 43.38 0 % -887.97
Operating Profit Margin 43.65 55.40 0 % -1061.87
EBITDA Margin 45.37 57.19 0 % -1061.87


Highlights
Market Cap1332.11 M
Enterprise Value1319.68 M
Price/Book TTM0.0136
Outstanding Share106569 K
Float/ Outstanding Share82.08%
Dividend Yield0 %
Share Holding
Guru Numbers
Price/Graham No0.0434
Peter Lynch Ratio0
Piotroski F Score6.00
Altman Z Score1218.52
Sloan Ratio-156.94
Peter Lynch Fair Value0


PNT - Growth Highlights

Growth Analysis

   Tsr Growth Index - Excellent Score of 86.25
   Steady increase in Total Assets for last 3 Years
Growth Key Fields
Field TTM YoY Growth QoQ Growth
Revenue 236044 M % 42.66 %
Gross Profit 9691.50 M % 42.66 %
EBITDA 107085 M 284373 % 5.95 %
Net Profit 81259.09 M 214234 % 2.50 %
EPS 786.66 86783.74 % NA


PNT - Stability Highlights

Stability Analysis

   Tsr Stability Index - Good Score of 75.00
   Altman Z Score of 1218.52 suggests good Stability
   Company is Debt Free
   Net Debt zero balance-sheet with high liquidity
   Cash ratio of 10.81
   Interest Coverage of -92891.72
Stability Key Ratios
Ratio Latest FY Yoy Change MRQ
Debt to Equity Ratio 0 0 % 0.0045
Cash Ratio 10.81 -63.88 %
Quick Ratio 23.06 -23.00 % 9.03
Shareholders Equity 89.95 -7.21 %
Debt to EBITDA 0 0 %


Historical Valuation Ratios of POINT Biopharma Global Inc

Historical Valuation Ratios
Loading ...

Historical Profitability Ratios of POINT Biopharma Global Inc

Historical Profitability Ratios
Loading ...

Historical Efficiency Ratios of POINT Biopharma Global Inc

Historical Efficiency Ratios
Loading ...

Historical Solvency Ratios of POINT Biopharma Global Inc

Historical Solvency Ratios
Loading ...


Note : All Data Generated at the End of Trading Hours (EOD Data)